| Product Code: ETC5261527 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Ireland continued to rely on corticosteroid imports from key countries including Netherlands, China, USA, Metropolitan France, and Belgium. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the market experienced a significant decline with a Compound Annual Growth Rate (CAGR) of -24.68% from 2020 to 2024. The growth rate in 2024 showed a slight improvement compared to the previous year, indicating a challenging market environment for corticosteroid imports in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Corticosteroid Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Corticosteroid Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Corticosteroid Market - Industry Life Cycle |
3.4 Ireland Corticosteroid Market - Porter's Five Forces |
3.5 Ireland Corticosteroid Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Corticosteroid Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Ireland Corticosteroid Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin conditions and respiratory diseases in Ireland |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various health conditions |
4.2.3 Rising healthcare expenditure and government initiatives to improve access to healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for corticosteroid products |
4.3.2 Concerns regarding potential side effects and long-term use of corticosteroids |
4.3.3 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) |
5 Ireland Corticosteroid Market Trends |
6 Ireland Corticosteroid Market Segmentations |
6.1 Ireland Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2021-2031F |
6.1.3 Ireland Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2021-2031F |
6.2 Ireland Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Ireland Corticosteroid Market Revenues & Volume, By Topical Steroids, 2021-2031F |
6.2.3 Ireland Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2021-2031F |
6.2.4 Ireland Corticosteroid Market Revenues & Volume, By Oral Forms, 2021-2031F |
6.2.5 Ireland Corticosteroid Market Revenues & Volume, By Systemic Forms, 2021-2031F |
6.2.6 Ireland Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
6.3 Ireland Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2021-2031F |
6.3.3 Ireland Corticosteroid Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.3.4 Ireland Corticosteroid Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.3.5 Ireland Corticosteroid Market Revenues & Volume, By Gastroenterology, 2021-2031F |
6.3.6 Ireland Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.3.7 Ireland Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
7 Ireland Corticosteroid Market Import-Export Trade Statistics |
7.1 Ireland Corticosteroid Market Export to Major Countries |
7.2 Ireland Corticosteroid Market Imports from Major Countries |
8 Ireland Corticosteroid Market Key Performance Indicators |
8.1 Prescription rates of corticosteroid products by healthcare professionals |
8.2 Patient adherence to corticosteroid treatment regimens |
8.3 Number of clinical trials and research studies on corticosteroids in Ireland |
9 Ireland Corticosteroid Market - Opportunity Assessment |
9.1 Ireland Corticosteroid Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Corticosteroid Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Ireland Corticosteroid Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Corticosteroid Market - Competitive Landscape |
10.1 Ireland Corticosteroid Market Revenue Share, By Companies, 2024 |
10.2 Ireland Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here